Geistlich Pharma AG
-
Chesterbrook’s Persevere Therapeutics Raises $1.57M, Acquires Cancer Drug in Stealth Exit
Chesterbrook-based Persevere Therapeutics marked its emergence from stealth mode last week with completed equity financing and product acquisition, writes John George for the Philadelphia Business…
Founding Partners
Advertisement
Affiliate Partners
